Financial Ratios

MEDICO REMEDIES LTD.

NSE : MEDICOBSE : 540937ISIN CODE : INE630Y01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE46.55-0.25 (-0.53 %)
PREV CLOSE ( ) 46.80
OPEN PRICE ( ) 46.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8312
TODAY'S LOW / HIGH ( )46.50 47.00
52 WK LOW / HIGH ( )44.53 100.79
NSE46.25-0.5 (-1.07 %)
PREV CLOSE( ) 46.75
OPEN PRICE ( ) 46.75
BID PRICE (QTY) 46.25 (1020)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 80133
TODAY'S LOW / HIGH( ) 46.00 47.30
52 WK LOW / HIGH ( )44.5 100.7
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.872.906.243.933.78
   CEPS(Rs)1.200.850.510.400.37
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)5.2822.0478.2271.9868.05
   Tax Rate(%)28.2925.7830.0026.4027.81
Margin Ratios
   Core EBITDA Margin(%)6.756.064.283.212.83
   EBIT Margin(%)7.725.903.773.693.23
   Pre Tax Margin(%)7.195.363.022.502.23
   PAT Margin (%)5.163.982.121.841.61
   Cash Profit Margin (%)7.095.813.463.723.15
Performance Ratios
   ROA(%)8.636.243.432.152.31
   ROE(%)18.0113.948.315.615.72
   ROCE(%)21.8815.0910.137.667.79
   Asset Turnover(x)1.671.571.621.171.44
   Sales/Fixed Asset(x)3.913.954.603.795.17
   Working Capital/Sales(x)6.106.235.965.487.11
Efficiency Ratios
   Fixed Capital/Sales(x)0.260.250.220.260.19
   Receivable days86.4087.1876.51109.0686.09
   Inventory Days49.1349.2548.9270.6957.88
   Payable days120.01135.32119.00187.40134.71
Valuation Parameters
   PER(x)85.615.790.800.931.12
   PCE(x)62.2319.839.799.2311.44
   Price/Book(x)14.143.811.281.021.25
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)4.461.220.440.480.49
   EV/Core EBITDA(x)46.1315.778.578.6810.33
   EV/EBIT(x)57.7020.6711.6313.0915.28
   EV/CE(x)7.031.880.710.570.63
   M Cap / Sales4.411.150.340.340.36
Growth Ratio
   Net Sales Growth(%)16.04-1.1238.08-9.2760.08
   Core EBITDA Growth(%)44.8949.3426.985.856.16
   EBIT Growth(%)51.7954.6641.113.85-6.98
   PAT Growth(%)50.4985.7958.863.8428.68
   EPS Growth(%)-69.90-53.5458.833.8428.68
Financial Stability Ratios
   Total Debt/Equity(x)0.180.290.460.460.48
   Current Ratio(x)1.531.491.541.401.30
   Quick Ratio(x)1.081.031.160.950.95
   Interest Cover(x)14.5210.795.023.093.22
   Total Debt/Mcap(x)0.010.080.360.460.38

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.